• Privacy Policy
  • Terms Of Service
  • Facebook
  • Twitter
  • LinkedIn
  • Instagram
Forex trading, free forex education | Forex.ca

 

  • Home
  • Forex News
  • Stock News
  • For Beginners
  • Market Analysis
  • Trading Strategies
  • Real Time Stock Update
  • Shop
News Ticker
  • [ September 30, 2025 ] Apellis Pharmaceuticals: Maintaining "Buy" Rating With Continued EMPAVELI Expansions Beyond PNH And C3G-Disorders Stock News
  • [ September 30, 2025 ] Virtus Newfleet Multi-Sector Short Term Bond Fund Q2 2025 Commentary Stock News
  • [ September 30, 2025 ] Tesla (TSLA) Share Price Rises Ahead of Earnings Report Forex News
  • [ September 29, 2025 ] Accenture: The Best Way To Play AI's Next Phase Stock News
  • [ September 29, 2025 ] Growth & Total Return Weekly Chat Stock News
Home2022

Year: 2022

Stock News

Autodesk Stock Can Outperform – Attractive Valuation (NASDAQ:ADSK)

March 27, 2022 admin 0

JHVEPhoto/iStock Editorial via Getty Images Autodesk (NASDAQ:ADSK) is an industry leader that has seen its valuation drop significantly in the past few months. As we begin to enter the middle portion of this new business […]

Stock News

Lemonade Stock: Building A Full Insurance Flywheel (NYSE:LMND)

March 27, 2022 admin 0

ipopba/iStock via Getty Images Right now, I’d encourage investors to think with a growth mindset and be open to taking on a little bit of risk. In the mere space of a few months, the […]

Stock News

Medicago’s tobacco ties jeopardize growth of its COVID shot By Reuters

March 27, 2022 admin 0

© Reuters. FILE PHOTO: The leaves of a Nicotiana benthamiana plant is pictured at Medicago greenhouse in Quebec City, August 13, 2014. REUTERS/Mathieu Belanger By Amruta Khandekar and Mrinalika Roy (Reuters) – Canadian vaccine maker […]

Posts navigation

« 1 … 24,199 24,200 24,201 … 25,381 »

For Beginners


Categories

  • Forex News
  • Stock News
No Picture
Stock News

Apellis Pharmaceuticals: Maintaining "Buy" Rating With Continued EMPAVELI Expansions Beyond PNH And C3G-Disorders

September 30, 2025 0

Apellis Pharmaceuticals: Maintaining "Buy" Rating With Continued EMPAVELI Expansions Beyond PNH And C3G-Disorders

Stock News

Virtus Newfleet Multi-Sector Short Term Bond Fund Q2 2025 Commentary

September 30, 2025 0

Follow Summary The second quarter of 2025 was defined by several key policies from the new Trump administration, including tariffs/trade, immigration, and taxes. The fund returned 1.88% in the second quarter versus the ICE BoA […]

Latest news
  • Tesla (TSLA) Share Price Rises Ahead of Earnings Report
    September 30, 2025 0
  • Nikkei 225 Rises Following Resignation of Prime Minister Shigeru Ishiba
    September 8, 2025 0
Random News
  • Onto Innovation Inc. (ONTO) Q3 2022 Earnings Call Transcript
    October 28, 2022 0
  • Why Altria Investors Should Root For A Steep Recession (NYSE:MO)
    September 7, 2022 0
  • MicroVision, Inc. 2022 Q2 – Results – Earnings Call Presentation (NASDAQ:MVIS)
    July 28, 2022 0
Email Inquiries to: warp1@sympatico.ca
  • No Picture
    Apellis Pharmaceuticals: Maintaining "Buy" Rating With Continued EMPAVELI Expansions Beyond PNH And C3G-Disorders
    September 30, 2025 0
  • Virtus Newfleet Multi-Sector Short Term Bond Fund Q2 2025 Commentary
    September 30, 2025 0
Pages
  • Contact Us
  • Home
  • Privacy Policy
  • Real Time Stock Update
  • Shop
  • Terms Of Service

© Copyright 2020-2023 Forex.ca

Please note that foreign exchange and other leveraged trading involves significant risk of loss. It is not suitable for all investors and you should make sure you understand the risks involved, seeking independent advice if necessary.